Skip to main content
Clinical Trials/NCT01017510
NCT01017510
Unknown
Not Applicable

Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

Sheba Medical Center1 site in 1 country20 target enrollmentNovember 2009
ConditionsAlopecia Areata

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alopecia Areata
Sponsor
Sheba Medical Center
Enrollment
20
Locations
1
Primary Endpoint
Evaluation of lesions will be based on Global assessment of improvement, score of 0-5
Last Updated
15 years ago

Overview

Brief Summary

Conventional treatments include the use of steroids applied locally, or injection in to the legion, or oral therapy.

Treatment is determined by the severity of the disease.

Injection in to the legion can be done in two methods

  1. Subcutaneous injection syringe Lower
  2. Using syringe DERMOJET - a syringe without a needle. So far there are no publications in the medical literature of studies comparing efficacy, safety, convenience of use for doctor-patient, of both methods.
Registry
clinicaltrials.gov
Start Date
November 2009
End Date
November 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Subjects over the age of 18
  • Men and women
  • The presence of at least two lesions (centers) in diameter of at least 1.5 cm on both sides of the scalp.
  • Healthy with no diseases that constitute the background against the total label use steroids

Exclusion Criteria

  • Pregnant women
  • Involvement of more then 50% of the scalp
  • Patients with immunodeficiency-related diseases
  • Patients receiving systemic steroids

Outcomes

Primary Outcomes

Evaluation of lesions will be based on Global assessment of improvement, score of 0-5

Time Frame: 1 year

Secondary Outcomes

  • Pain level will be evaluated based on a scale of 0-10(1 year)

Study Sites (1)

Loading locations...

Similar Trials